User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
Institutional References Quartile Statistics FAQ User Guide Contact us
Institutional Application Application for Journals
Türkçe English
 ASOS INDEKS
 Views 12
Menu
Mendeley
Endnote
New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100
2012
Journal:  
Bulletin of Urooncology
Author:  
Abstract:

Treatment of metastatic castration resistant prostate cancer after progression from Docetaxel chemoterapy nowadays have many alternatives. Re-tereatment with docetaxel have shown PSA response but most of the studies are retrospective and non randomised. Abiraterone acetate and recently MDV3100 as an oral antiandrogen agent have shown significant survival advantage without major toxicity and stays as a main drug. Cabazitaxel in combination with prednisone is the only chemoterapic agent to have shown significant survival benefit but have a toxicity problems. İn this review we summarize the current evidence.

Keywords:

Citation Owners
Information: There is no ciation to this publication.
Similar Articles
1. Are there any treatment option for metastatic prostate cancer refractory to docetaksel?
2011


  Details
 Download PDF
2. New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
2013


  Details
 Download PDF
3. New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate
2013


  Details
 Download PDF
4. Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer
2015


  Details
 Download PDF
5. Hormonal treatment of metastatic prostate cancer: Today and future
2011


  Details
 Download PDF
6. Hormon resistan prostat kanserinde sipuleucel-T immünoterapisi
2010


  Details
 Download PDF
Bulletin of Urooncology

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 112
Cite : 2
2023 Impact : 0.012
Details
Bulletin of Urooncology